COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Catharina Belge,
Rozenn Quarck,
Laurent Godinas,
David Montani,
Pilar Escribano Subias,
Jean-Luc Vachiéry,
Heba Nashat,
Joanna Pepke-Zaba,
Marc Humbert,
Marion Delcroix
Affiliations
Catharina Belge
Clinical Dept of Respiratory Diseases, University Hospitals and Laboratory of Respiratory Diseases & Thoracic Surgery (BREATHE), Dept of Chronic Diseases & Metabolism (CHROMETA), KU Leuven – University of Leuven, Leuven, Belgium
Rozenn Quarck
Clinical Dept of Respiratory Diseases, University Hospitals and Laboratory of Respiratory Diseases & Thoracic Surgery (BREATHE), Dept of Chronic Diseases & Metabolism (CHROMETA), KU Leuven – University of Leuven, Leuven, Belgium
Laurent Godinas
Clinical Dept of Respiratory Diseases, University Hospitals and Laboratory of Respiratory Diseases & Thoracic Surgery (BREATHE), Dept of Chronic Diseases & Metabolism (CHROMETA), KU Leuven – University of Leuven, Leuven, Belgium
David Montani
Univ. Paris–Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France
Pilar Escribano Subias
Cardiology Dept and Spanish Cardiovascular Research Network (CIBER-CV), Hospital Universitario 12 de Octubre, Madrid, Spain
Jean-Luc Vachiéry
Dept of Cardiology, Cliniques Universitaires de Bruxelles, Hôpital Académique Erasme, Brussels, Belgium
Heba Nashat
National Pulmonary Hypertension Service at Royal Brompton and Harefield NHS Trust and National Heart and Lung Institute, Imperial College London, London, UK
Joanna Pepke-Zaba
Pulmonary Vascular Diseases Unit, Royal Papworth Hospital, Cambridge, UK
Marc Humbert
Univ. Paris–Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France
Marion Delcroix
Clinical Dept of Respiratory Diseases, University Hospitals and Laboratory of Respiratory Diseases & Thoracic Surgery (BREATHE), Dept of Chronic Diseases & Metabolism (CHROMETA), KU Leuven – University of Leuven, Leuven, Belgium
